Injection site reactions glatiramer

Glatiramer acetate (Copaxone) 20 mg SQ Daily Injection site reaction 90% Systemic reaction 15%... 

Most common adverse effects in controlled trials include injection site reactions, vasodilatation, chest pain, asthenia, infection, pain, nausea, arthralgia, anxiety, and hypertonia. About 10% of patients experience an immediate post-injection reaction (flushing, chest pain, palpitations, anxiety, dyspnea, throat constriction, and urticaria). The symptoms are hansient and self-limited, and usually do not require specific heatment. Transient chest pain was noted in 21% of Copaxone patients versus 11% in the placebo group with no long-term sequelae. Unlike therapy with the IFNps, glatiramer acetate is not associated with flu-like symptoms. 

Multiple sclerosis Beta interferons, glatiramer acetate, glucocorticoids, antispasmodics, amantadine, stimulants, immunosuppressants Number of exacerbations, self-injection technique, injection site reactions, amount of spasticity, amount of fatigue, CBC and infections (immunosuppressants), medication-specific adverse effects... 

---